On July 31st, the New York Giants announced via Twitter that second-year safety Tyler Sash will be serving a four-game suspension for violating the league's policy on performance-enhancing substances.
Through a statement released by the Giants, Sash said that he was taking prescription Adderall to treat an anxiety condition, and he wasn't aware that the drug was banned by the NFL. Sash was adamant in insisting that this positive test was in no way associated with performance-enhancing drugs.
This is a blow to the defending champion G-Men on many fronts. Let's go over just how much this affects the Giants, who are on their quest to become the first NFL team to successfully defend their title in seven seasons.